Oct. 27, 2014—Vanderbilt students explored the opportunities and challenges of setting policy on federal issues and advocacy related to science, technology, engineering and math during a two-day immersion event last week in Washington, D.C.
Mar. 24, 2014—By shifting evolution into reverse to produce an expensive HIV drug out of a simple sugar, Vanderbilt chemist Brian Bachmann has shown that it may be possible to manufacture exotic and expensive synthetic drugs as easily as brewing beer.
Feb. 18, 2014—The mechanical forces generated by the rhythmic expansion and contraction of cardiac muscle cells play an active role in the initial stage of heart valve formation.
Jul. 31, 2013—Get ready to see stars– We’re taking you to space camp. See why mosquitoes bite you more than others Why you should get “Pinterested” in Vanderbilt! All this and more in this week’s VUCast, Vanderbilt’s online newscast. Watch now.
Jul. 5, 2013—The strength of Vanderbilt biochemistry, especially in the area of metabolism and diabetes, has a lot to do with a brilliant husband-and-wife research team escaping the rise of Nazism in the early 1920s.
May. 2, 2013— Joseph Parello, Ph.D, visiting scholar in the Department of Pharmacology, received the insignia of the Knight of the Legion of Honor April 30 in Cohen Memorial Hall on Vanderbilt’s campus. Created in 1802 by Napoleon Bonaparte, the Legion of Honor is the highest decoration of France. It recognizes distinguished service to the French Republic...
Feb. 7, 2013—A team led by Vanderbilt University investigators has discovered two new genes — both coding for the signaling protein calmodulin — associated with severe early-onset disorders of heart rhythm.
Jan. 24, 2013—Vanderbilt University’s Lee Limbird, Ph.D., has received one of pharmacology’s highest honors — the 2013 Julius Axelrod Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET).
Jan. 18, 2013—Understanding how the main receptor for light interacts with other signaling molecules may inform new pharmaceutical development.
Oct. 25, 2012—Heidi Hamm, Ph.D., chair of the Department of Pharmacology, has won the 2012 Ariens Award from the Dutch Pharmacological Society.
Aug. 30, 2012—The spinal cord’s neuropeptide Y signaling pathway may be a good target for new pain therapeutics.
Aug. 28, 2012—A reversible chemical modification of rhodopsin, a receptor for light, plays a role in the degeneration of retinal cells.